Healthcare Industry Synthetic Biology Market Research Report 2024 | Page 4

Your Catalyst To a Lucrative Business
5.3. Biological components
5.3.1. Global biological components demand, 2016 - 2024 (USD Million)
5.4. Integrated Systems and Bioinformatics
5.4.1. Global integrated systems and bioinformatics demand, 2016 - 2024 (USD Million)
Chapter 6. Synthetic biology Regional Outlook
6.1. North America
6.1.1. North America synthetic biology revenue by product, 2016 - 2024 (USD Million)
6.1.2. North America synthetic biology revenue by application, 2016 - 2024 (USD Million)
6.1.3. North America synthetic biology revenue by technology, 2016 - 2024 (USD Million)
6.2. Europe
6.2.1. Europe synthetic biology revenue by product, 2016 - 2024 (USD Million)
6.2.2. Europe synthetic biology revenue by application, 2016 - 2024 (USD Million)
6.2.3. Europe synthetic biology revenue by technology, 2016 - 2024 (USD Million)
6.3. Asia Pacific
6.3.1. Asia Pacific synthetic biology revenue by product, 2016 - 2024 (USD Million)
6.3.2. Asia Pacific synthetic biology revenue by product application, 2016 - 2024 (USD Million)
6.3.3. Asia Pacific synthetic biology revenue by product technology, 2016 - 2024 (USD Million)
6.4. RoW
6.4.1. RoW synthetic biology revenue by product, 2016 - 2024 (USD Million)
6.4.2. RoW synthetic biology revenue by product application, 2016 - 2024 (USD Million)
6.4.3. RoW synthetic biology revenue by product technology, 2016 - 2024 (USD Million)
Companies analyzed in competitive landscape
1. Amyris Inc..
2. Agrivida Inc.
3. Algenol Biofuels Inc.
4. Bayer AG
5. ATG:biosynthetics GmbH
6. CBC Comprehensive Biomarker Center GmbH
7. Bioneer Corporation
8. Bristol-Myers Squibb
9. Biosearch Technologies Inc.
10. Gene Script Corporation
11. GeneWorks Pty Ltd.
12. Ginkgo Bioworks
13. Exxon Mobil Corporation
14. Evolva SA
15. DuPont Inc.
16. Cobalt Technologies
17. New England Biolabs, Inc.
Follow Us: